Skip to main content
Premium Trial:

Request an Annual Quote

Magellan, Bruker Combining Technologies for Microbial Identification

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Magellan Biosciences today announced a deal with Bruker combining their technologies for microbial identification.

Under the terms of the deal, Magellan will develop and test an integrated cross-platform software interface for microbial identification gathered on Bruker's MALDI Biotyper mass spectrometer-based platform combined with results from Magellan's Trek-brand Sensititre susceptibility-testing platform.

Magellan will market and sell the products developed from the deal, the Chelmsford, Mass.-based company said, adding that the products are expected to improve the microbiology laboratory workflow for clinical, research, and veterinary customers.

Magellan did not disclose financial or other terms of the deal.

The MALDI Biotyper has been available in Europe with an IVD-CE mark and is labeled for research-use-only in the US. Bruker plans to seek approval from the US Food and Drug Administration and with regulators in Australia and Canada for the platform.

As a result of the partnership, the MALDI Biotyper's ability to rapidly identify more than 2,000 species of bacteria, yeast and fungi, along with Sensititre's capabilities will create "an expansive list of antimicrobial drugs and dilution ranges, enabling physicians to make more precise dosing decisions," Magellan President and CEO Hiroshi Uchida said in a statement.

Earlier this week, Magellan announced a deal with Miacom Diagnostics to bring that firm's molecular tests to the US and Canada.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.